ZNTL - Zentalis Pharmaceuticals prices common stock

2023-06-15 06:05:27 ET

• Zentalis Pharmaceuticals ( NASDAQ: ZNTL ) prices a common stock offering of 11.03M at $22.66 per share, for total gross proceeds of ~$250M.
• The offering is expected to close on June 20, 2023.
• Net proceeds from the offering will be used to fund ongoing and planned clinical trials, and for working capital and other general corporate purposes. The net proceeds along with the existing cash, cash equivalents and marketable securities will be sufficient to fund its operating expenses and capital expenditure requirements into 2026.
• Source: Press Release

For further details see: